‹ All Posts
Shaly Gupta

11th Feb 2025 · SEBI-Registered Analyst

Lupin

Lupin: Company gets U.S. FDA approval for its Abbreviated New Drug Application for Ipratropium Bromide Nasal Solution

LUPIN
Stock have a good support at 2000 levels.

#WatchOutFor#StockInNews#Today’sTradingSetup#Budget2025#IndexStrategies
LUPIN_2025-02-11_11-34-22.png